Interleukin-13 in asthma pathogenesis

Immunological Reviews

Volumn 202, Issue , 2004, Pages 175-190

  Wills Karp, Marsha ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 5; INTERLEUKIN 9; STAT6 PROTEIN;

AIRWAY; ALLERGIC ASTHMA; ALLERGIC DISEASE; ALLERGY; ANIMAL MODEL; ASTHMA; BRONCHUS MUCOSA; CALCIUM TRANSPORT; CELL POLARITY; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DESENSITIZATION; EOSINOPHIL; EPITHELIUM CELL; FIBROBLAST; FIBROSIS; GENE CONTROL; GENE EXPRESSION; GENE INDUCTION; GENE MUTATION; GENETIC TRANSFECTION; GENETIC VARIABILITY; GOBLET CELL; HUMAN; IMMUNE RESPONSE; INFLAMMATORY CELL; LYMPHOCYTE DIFFERENTIATION; MEDIATOR RELEASE; MUCUS SECRETION; MULTIGENE FAMILY; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN TRANSPORT; REVIEW; T LYMPHOCYTE ACTIVATION; TH2 CELL; UPREGULATION;

ASTHMA; HUMANS; HYPERSENSITIVITY; INFLAMMATION; INTERLEUKIN-13; INTERLEUKIN-13 RECEPTOR ALPHA1 SUBUNIT; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-13; RESPIRATORY SYSTEM; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; TH2 CELLS;

EID: 9644281044     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0105-2896.2004.00215.x     Document Type: Review

References (107)

1. Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol 1999;17:255-281.
2. Zurawski G, deVries J. Interleukin-13, an interleukin-4 like cytokine that acts on monocytes and B cells but not T-cells. Immunol Today 1994;15:19-26.
3. Zurawski SM, Vega F, Juyghe B, Zurawski G. Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction. EMBO J 1993;12:2663-2670.
4. Akbari O, et al. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat Med 2003;9:582-588.
5. Schmid-Grendelmeier P, et al. Eosinophils express functional IL-13 in eosinophilic inflammatory diseases. J Immunol 2002;169:1021-1027.
6. Mattes J, et al. Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma. J Exp Med 2002;195:1433-1444.
7. Grunstein MM, et al. IL-13-dependent autocrine signaling mediates altered responsiveness of IgE-sensitized airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2002;282:L520-L528.
8. Temann UA, Geba GP, Rankin JA, Flavell RA. Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness. J Exp Med 1998;188:1307-1320.
9. Fort MM, et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 2001;15:985-995.
10. Temann UA, Ray P, Flavell RA. Pulmonary overexpression of IL-9 induces Th2 cytokine expression, leading to immune pathology. J Clin Invest 2002;109:29-39.
11. Hurst SD, et al. New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25. J Immunol 2002;169:443-453.
12. Elliott KA, Osna NA, Scofield MA, Khan MM. Regulation of IL-13 production by histamine in cloned murine T helper type 2 cells. Int Immunopharmacol 2001;1: 1923-1937.
13. Blackburn MR, et al. Adenosine mediates IL-13-induced inflammation and remodeling in the lung and interacts in an IL-13-adenosine amplification pathway. J Clin Invest 2003:112:332-344.
14. Ryzhov S, Goldstein AE, Matafonov A, Zeng D, Biaggioni I, Feoktistov I. Adenosine-activated mast cells induce IgE synthesis by B lymphocytes, an A2B-mediated process involving Th2 cytokines IL-4 and IL-13 with implications for asthma. J Immunol 2004;172:7726-7733.
15. Cui P, et al. Endothelin-1 peptides and IL-5 synergistically increase the expression of IL-13 in eosinophils. Biochem Biophys Res Commun 2004:315:782-787.
16. Hilton DJ, Zhang J-G, Metcalf D, Alexander WS, Nicols NA, Wilson TA. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of interleukin 4 receptor. Proc Natl Acad Sci USA 1996;93:497-501.
17. Aman MJ, Tayebi N, Obii NI, Puri RK, Modi WS, Leonard WJ. cDNA cloning and characterization of the human interleukin-13 receptor alpha chain. J Biol Chem 1996:271:29265-29270.
18. Caput D, Laurent P, Kaghad M, Lelias JM, Lefort S, Vita N, Ferrara P. Cloning and characterization of specific interleukin (IL)-13 binding protein and structurally related to the IL-5 receptor α chain. J Biol Chem 1996:271:16921-16926.
19. Zurawski S, et al. The primary binding subunit of the human interleukin-4-receptor is also a component of the interleukin-13 receptor. J Biol Chem 1995:270: 13869-13878.
20. Graber P, Gretener D, Herren S, Aubry JP, Elson G, Poudrier J. The distribution of IL-13 receptor alpha 1 expression on B cells, T cells, and monocytes and its regulation by IL-13 and IL-4. Eur J Immunol 1998:28:4286-4298.
21. Kaplan M, Schindler U, Smiley S, Grusby M. STAT6 is required for mediating responses to IL-4 and for the development of Th2 cells. Immunity 1996;4:313-319.
22. Kuperman D, Schofield B, Wills-Karp M, Grusby MJ. Signal transducer and activator of transcription factor 6 (Stat6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production. J Exp Med 1998:187:939-948.
23. Brusselle G, Kips J, Joos G, Bluethmann H, Pauwels R. Allergen-induced airway inflammation and bronchial responsiveness in wildtype and interleukin-4-deficient mice. Am J Respir Cell Mol Biol 1995;12:254-259.
24. Coyle AJ, et al. Interleukin-4 is required for the induction of lung Th2 mucosal immunity. Am J Respir Cell Mol Biol 1995;13:54-59.
25. Cohn L, Tepper JS, Bottomly K. IL-4-independent induction of airway hyperresponsiveness by Th2, but not Th1, cells. J Immunol 1998:161:3813-3816.
26. Gavett SH, et al. Interleukin-4 receptor blockade prevents airway responses induced by antigen challenge in mice. Am J Physiol 1997;272:L253-L261.
27. Wills-Karp M, et al. Interleukin-13: central mediator of allergic asthma. Science 1998;282:2258-2261.
28. Grunig G, et al. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 1998;282:2261-2263.
29. Zhu Z, et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 1999;103:779-788.
30. Webb DC, McKenzie AN, Koskinen AM, Yang M, Mattes J, Foster PS. Integrated signals between IL-13, IL-4 and IL-5 regulate airways hyperreactivity. J Immunol 2000;165:108-113.
31. Walter DM, et al. Critical role for IL-13 in the development of allergen-induced airway hyperreactivity. J Immunol 2001;167: 4668-4675.
32. Webb DC, Matthaei KI, Cai Y, McKenzie AN, Foster PS. Polymorphisms in IL-4R alpha correlate with airways hyperreactivity, eosinophilia, and Ym protein expression in allergic IL-13-/- mice. J Immunol 2004:172:1092-1098.
33. Rankin JA, et al. Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: lymphocytic and eosinophilic inflammation without airway hyperreactivity. Proc Natl Acad Sci USA 1996:93:7821-7825.
34. Kroegel C, Julius P, Matthys H, Virchow JC Jr, Luttmann W. Endobronchial secretion of interleukin-13 following local allergen challenge in atopic asthma: relationship to interleukin-4 and eosinophil counts. Eur Respir 1996;9:899-904.
35. Mattes J, et al. IL-13 induces airways hyperreactivity independently of the IL-4R alpha chain in the allergic lung. J Immunol 2001;167:1683-1692.
36. Donaldson DD, et al. The murine IL-13 receptor alpha 2: molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1. J Immunol 1998;161:2317-2324.
37. Daines MO, Hershey GK. A novel mechanism by which interferon-gamma can regulate interleukin (IL)-13 responses. Evidence for intracellular stores of IL-13 receptor alpha-2 and their rapid mobilization by interferon-gamma. J Biol Chem 2002;277:10387-10393.
38. Yasunaga S, et al. The negative feedback regulation of the IL-13 signal by the IL-13 receptor α2 chain in bronchial epithelial cells. Cytokine 2003;24:293-303.
39. Chiaramonte MG, et al. Regulation and function of the interleukin 13 receptor a 2 during a T helper cell type-2-dominant immune response. J Exp Med 2003;197: 687-701.
40. Trieu Y, et al. Soluble interleukin-13RA2 decoy receptor inhibits Hodgkin's Lymphoma growth in vitro and in vivo. Can Res 2004;64:3271-3275.
41. Dienger KM, Herman NS, Donaldson D, Grusby M, Wills-Karp M. The complex role of IL-13 receptor alpha 2 knockout mice in allergic responses. Am J Respir Crit Care Med 2003;167:A727.
42. Zheng T, et al. Cytokine regulation of IL-13Ralpha2 and IL-13Ralpha1 in vivo and in vitro. J Allergy Clin Immunol 2003:111:720-728.
43. Zhang JG, et al. Identification, purification, and characterization of a soluble interleukin (IL)-13-binding protein: Evidence that it is distinct from the cloned IL-13 receptor and IL-4 receptor α-chains. J Biol Chem 1997;272:9474-9480.
44. Zheng T. Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase-and cathepsin-dependent emphysema. J Clin Invest 2000;106:1081-1093.
45. Wills-Karp M, Chiaramonte M. Interleukin-13 in asthma. Curr Opin Pulm Med 2003:9:21-27.
46. Bochner BS, Klunk DA, Sterbinsky SA, Coffman RL, Schleimer RP. IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. J Immunol 1995;154:799-803.
47. Lukacs NW, et al. Respiratory syncytial virus predisposes mice to augmented allergic airway responses via IL-13-mediated mechanisms. J Immunol 2001:167:1060-1065.
48. Zhu Z, et al. IL-13-induced chemokine responses in the lung: role of CCR2 in the pathogenesis of IL-13-induced inflammation and remodeling. J Immunol 2002:168: 2953-2962.
49. Schuh JM, Blease K, Kunkel SL, Hogaboam CM. Chemokines and cytokines axis and allies in asthma and allergy. Cytokine Growth Factor Rev 2003;14:503-510.
50. Zimmerman N, Hershey GK, Foster PS, Rothenberg ME. Chemokines in asthma, cooperative interaction between chemokines and IL-13. J Allergy Clin Immunol 2003:111:227-242.
51. Faffe DS, et al. IL-13 and IL-4 promote TARC release in human airway smooth muscle cells: role of IL-4 receptor genotype. Am J Physiol Lung Cell Mol Physiol 2003;285:L907-L914.
52. Ma B, Zhu Z, Homer RJ, Gerard C, Strieter R, Elias JA. The C10/CCL6 chemokine and CCR1 play critical roles in the pathogenesis of IL-13-induced inflammation and remodeling. J Immunol 2004;172:1872-1881.
53. Corry DB, et al. Overlapping and independent contributions of MMP2 and MMP9 to lung allergic inflammatory cell regression through decreased CC chemokines. FASEB J 2004;18:995-997.
54. Lanone S, et al. Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13-induced inflammation and remodeling. J Clin Invest 2002;110:463-474.
55. Chiaramonte MG, Donaldson DD, Cheever AW, Wynn TA. An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. J Clin Invest 1999;104:777-785.
56. Hasegawa M, Fujimoto K, Kikuchi K, Takehara K. Elevated serum levels of IL-14 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis. J Rheumatol 1997:24:328-332.
57. Hesse M, et al. Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/ type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of 1-arginine metabolism. J Immunol 2001:167:6533-6544.
58. Zimmermann N, et al. Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. J Clin Invest 2003;111: 1863-1874.
59. Lee CG, et al. Interleukin-13 induces tissue fibrosis by simulating and activating transforming growth factor beta (1). J Exp Med 2001;194:809-821.
60. Wen FQ, et al. Interleukin-4- and interleukin-13-enhanced transforming growth factor-beta2 production in cultured human bronchial epithelial cells is attenuated by interferon-gamma. Am J Respir Cell Mol Biol 2002:26:484-490.
61. Hogaboam CM, et al. Differential monocyte chemoattractant protein-1 and chemokine receptor 2 expression by murine lung fibroblasts derived from Th1- and Th2-type pulmonary granuloma models. J Immunol 1999;163:2193-2201.
62. Ingram JL, Rice A, Geisenhoffer K, Madtes DK, Bonner JC. Interleukin-13 stimulates the proliferation of lung myofibroblasts via a signal transducer and activator of transcription-6-dependent mechanism: a possible mechanism for the development of airway fibrosis in asthma. Chest 2003;123:422S-424S.
63. Cohn L, Homer RJ, MacLeod H, Mohrs M, Brombacher F, Bottomly K. Th2-induced airway mucus production is dependent on IL-4 Ralpha, but not on eosinophils. J Immunol 1999;162:6178-6183.
64. Dudley KL, Chiaramonte M, Wills-Karp M. Upregulation of mucin related genes is associated with susceptibility to allergen-induced hyperresponsiveness. Am J Respir Crit Care Med 2002;163:A693.
65. Booth BW, Adler KB, Bonner JC, Tournier F, Martin LD. Interleukin-13 induces proliferation of human airway epithelial cells in vitro via a mechanism mediated by transforming growth factor-alpha. Am J Respir Cell Mol Biol 2001;25:739-743.
66. Laoukili J, et al. IL-13 alters mucociliary differentiation and ciliary beating of human respiratory epithelial cells. J Clin Invest 2001;108:1817-1824.
67. Danahay H, Atherton H, Jones G, Bridges RJ, Poll CT. Interleukin-13 induces a hypersecretory ion transport phenotype in human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol 2002;282:L226-L236.
68. Wan H, et al. Foxa2 regulates alveolarization and goblet cell hyperplasia. Development 2003;131:953-964.
69. Nakanishi A, et al. Role of gob-5 in mucus overproduction and airway hyperresponsiveness in asthma. Proc Natl Acad Sci USA 2001;98:5175-5180.
70. Zhou Y, et al. Characterization of a calcium-activated chloride channel as a shared target of Th2 cytokine pathways and its potential involvement in asthma. Am J Respir Cell Mol Biol 2001:25:486-491.
71. Leverkoehne I, Gruber AD. The murine mCLCA3 (alias gob-5) protein is located in the mucin granule membranes of intestinal, respiratory, and uterine goblet cells. J Histochem Cytochem 2002:50:829-838.
72. Vargaftig BB, Singer M. Leukotrienes, IL-13, and chemokines cooperate to induce BHR and mucus in allergic mouse lung. Am J Physiol Cell Mol Physiol 2003;284:L260-L269.
73. Vargaftig BB, Singer M. Leukotrienes mediate murine bronchopulmonary hyperreactivity, inflammation, and part of mucosal metaplasia and tissue injury induced by recombinant murine interleukin-13. Am J Respir Cell Mol Biol 2003;28:410-419.
74. Singer M, Lefort J, Vargaftig BB. Granulocyte depletion and dexamethasone differentially modulate airways hyperreactivity, inflammation, mucus accumulation, and secretion induced by rmIL-13 or antigen. Am J Respir Cell Mol Biol 2002;26:74-84.
75. Venkayya R, Lam M, Willkom M, Grunig G, Corry DB, Erie DJ. The Th2 lymphocyte products IL-4 and IL-13 rapidly induce airway hyperresponsiveness through direct effects on resident airway cells. Am J Respir Cell Mol Biol 2002:26:202-208.
76. Kibe A, et al. Differential regulation by glucocorticoid of interleukin-13-induced eosinophilia, hyperresponsiveness and goblet cell hyperplasia in mouse airways. Am J Respir Crit Care Med 2003;167:50-56.
77. Yang M, et al. Interleukin-13 mediates airways hyperreactivity through the IL-4 receptor-alpha chain and STAT-6 independently of IL-5 and eotaxin. Am J Respir Cell Mol Biol 2001;25:522-530.
78. Tliba O, et al. IL-13 enhances agonist-evoked calcium signals and contractile responses in airway smooth muscle. Br J Pharmacol 2003:140:1159-1162.
79. Grunstein MM, Hakonarson H, Leiter J, Chen M, Whelan R, Grunstein JS, Chuang S. IL-13-dependent autocrine signaling mediated altered responsiveness of IgE-sensitized airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2002;282:L520-L528.
80. Moore PE, Calder M, Amrani Y, Panettieri RA Jr, Shore SA. Effect of Th2 cytokines on human airway smooth muscle responses to LTD4. Am J Respir Crit Care Med 2002;165:A116.
81. Espinosa K, Bosse Y, Stankova J, Rola-Pleszczynski M. CysLT1 receptor upregulation by TGF-beta and IL-13 is associated with bronchial smooth muscle cell proliferation in response to LTD4. J Allergy Clin Immunol 2003:111:1032-1040.
82. Deshpande DA, et al. Modulation of calcium signaling by IL-13 in human airway smooth muscle: role of CD38/cyclic adenosine diphosphate ribose pathway. Am J Respir Cell Mol Biol 2004:31:36-42.
83. Laporte JC, et al. Direct effects of interleukin-13 on signaling pathways for physiological responses in cultured human airway smooth muscle cells. Am J Respir Crit Care Med 2001;164:141-148.
84. Wen FQ, et al. Th2 cytokine-enhanced and TGF-β-enhanced vascular endothelial growth factor production by cultured human airway smooth muscle cells is attenuated by IFN-gamma and corticosteroids. J Allergy Clin Immunol 2003:111:1307-1318.
85. Kazi AS, et al. Vascular endothelial growth factor-induced secretion of fibronectin is ERK-dependent. AM J Physiol Lung Cell Mol Physiol 2004;286:L539-L545.
86. Kuperman DA, et al. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat Med 2002:8:885-889.
87. Meurs H, et al. Increased arginase activity underlies allergen-induced deficiency of cNOS-derived nitric oxide and airway hyperresponsiveness. Br J Pharmacol 2002:136:391-398.
88. Dienger KM, Wills-Karp M. Interleukin-13 regulation of complement factor 3 production by human bronchial epithelial cells. Am J Respir Crit Care Med 2002;165:A733.
89. Bautsch W, et al. Cutting edge: guinea pigs with a natural C3a-receptor defect exhibit decreased bronchoconstriction in allergic airway disease: evidence for an involvement of the C3a anaphylatoxin in the pathogenesis of asthma. J Immunol 2000;165:5401-5405.
90. Humbles AA, et al. A role for the C3a anaphylatoxin receptor in the effector phase of asthma. Nature 2000;406:998-1001.
91. Walters DM, Breysse PN, Schofield B, Wills-Karp M. Complement factor 5 mediates particulate matter-induced airway hyperresponsiveness. Am J Respir Cell Mol Biol 2002;27:413-418.
92. Zhu A, et al. Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathways activation. Science 2004:304:1678-1682.
93. Vermaelen KY, et al. Matrix metalloproteinase-9-mediated dendritic cell recruitment into the airways is a critical step in a mouse model of asthma. J Immunol 2003:171:1016-1022.
94. Sakata Y, et al. The squamous cell carcinoma antigen 2 inhibits the cysteine proteinase activity of a major mite allergen. Der p 1. J Biol Chem 2004:279:5081-5087.
95. Kheradmand F, Kiss A, Xu J, Lee S-H, Kolattukudy PE, Corry DB. A protease activated pathway underlying Th cell type 2 activation and allergic lung disease. J Immunol 2002;169:5904-5911.
96. Huang SK, et al. IL-13 expression at the sites of allergen challenge in patients with asthma. J Immunol 1995;155:2688-2694.
97. Humbert M, et al. Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma. J Allergy Clin Immunol 1997;99:657-665.
98. Ying S, et al. Association between IL-13 and IL-4 (mRNA and protein), vascular cell adhesion molecule-1 expression and the infiltration of eosinophils, macrophages, and T cells in allergen-induced late-phase cutaneous reactions in atopic subjects. J Immunol 1997;158:5050-5057.
99. Naseer T, et al. Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy. Am J Respir Crit Care Med 1997;155:845-851.
100. Ohshima Y, et al. Dysregulation of IL-13 production by cord blood CD4+ T cells is associated with the subsequent development of atopic disease in infants. Pediatr Res 2002;51:195-200.
101. van der Pouw Kraan TC, et al. An IL-13 promoter polymorphism associated with increased risk of allergic asthma. Genes Immun 1999;1:61-65.
102. Graves PE, et al. A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children. J Allergy Clin Immunol 2000;105:506-513.
103. Heinzmann A, et al. Genetic variants of IL-13 signaling and human asthma and atopy. Hum Mol Genet 2000:9:549-559.
104. Celedon JC, et al. Lack of association between a polymorphism in the interleukin-13 gene and total serum immunoglobulin E level among nuclear families in Costa Rica. Clin Exp Allergy 2002:32:387-390.
105. Arima K, et al. Upregulation of IL-13 concentration in vivo by the IL13 variant associated with bronchial asthma. J Allergy Clin Immunol 2002:109:980-987.
106. Hoffjan S, Ober C. Present status of the genetic studies of asthma. Curr Opin Immunol 2002:14:709-717.
107. Howard TD, et al. Gene-gene interaction in asthma: IL4RA and IL13 in a Dutch population with asthma. Am J Hum Genet 2002:70:230-236.